Nanoparticulate carvedilol formulations

Details for Australian Patent Application No. 2007221471 (hide)

Owner Elan Pharma International Ltd.

Inventors Liversidge, Gary; Jenkins, Scott

Agent Davies Collison Cave

Pub. Number AU-A-2007221471

PCT Pub. Number WO2007/100466

Priority 11/363,266 28.02.06 US

Filing date 9 February 2007

Wipo publication date 7 September 2007

International Classifications

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 9/51 (2006.01) Medicinal preparations characterised by special physical form - Nanocapsules

A61K 31/403 (2006.01) - condensed with carbocyclic rings, e.g. carbazole

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

18 September 2008 PCT application entered the National Phase

  PCT publication WO2007/100466 Priority application(s): WO2007/100466

6 September 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007221495-Novel dual action receptors antagonists (DARA) at the AT1 and ETA receptors

2007221470-Phosphatase inhibitor Protein-1 as a regulator of cardiac function